These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7268304)

  • 1. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
    Koslík S; Takác M
    Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
    [No Abstract]   [Full Text] [Related]  

  • 2. [Levels of serum lipids and lipoproteins in renal disease].
    Synková J; Groh J; Sedová J; Mejtská M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(3):373-84. PubMed ID: 6977835
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
    Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
    Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Haemodialysis in children (author's transl)].
    Wolf A; Balzar E; Pinggera WF; Stummvoll HK
    Wien Klin Wochenschr; 1980 Jan; 92(2):35-42. PubMed ID: 6990630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin--does it favourably affect lipid levels?
    Stenvinkel P
    Nephrol Dial Transplant; 1995; 10(1):16-8. PubMed ID: 7724021
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in glucose tolerance, insulin, serum lipids and lipoproteins in patients with renal failure on intermittent haemodialysis.
    Arora KK; Atkinson MK; Trafford JA; Sheldon J; Nunn R
    Postgrad Med J; 1973 May; 49(571):293-6. PubMed ID: 4804451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
    Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
    Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic renal failure and arterial hypertension with "favourable" and "unfavourable" response to haemodialysis--haemodynamic changes in patients (author's transl)].
    Tomásek R; Horký K; Ort J; Lachmanová J; Straková M; Benes R
    Cas Lek Cesk; 1980 Aug; 119(33-34):897-902. PubMed ID: 7438159
    [No Abstract]   [Full Text] [Related]  

  • 12. [HDL-cholesterol in chronic renal failure and renal transplant (author's transl)].
    Masdeu S; Rubiés-Prat J; Nubiola AR; Ras MR; Masana L
    Med Clin (Barc); 1981 Oct; 77(7):280-3. PubMed ID: 7033690
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmatic renin activity in patients in chronic intermittent haemodialysis program and after renal transplantation (author's transl)].
    Karlícek V; Topolcan O; Opatrný K; Podzimek A; Novák V
    Cas Lek Cesk; 1974 Jan; 113(2):33-7. PubMed ID: 4611626
    [No Abstract]   [Full Text] [Related]  

  • 16. [Subcutaneous calcium heparin in hemodialysis (author's transl)].
    Molinari ML; Zoni G
    Haematologica; 1975 Dec; 60(4):466-76. PubMed ID: 816716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adequacy of haemodialysis in the treatment of chronic renal insufficiency (author's transl)].
    Twardowski Z
    Przegl Lek; 1974; 31(4):457-61. PubMed ID: 4840047
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in serum levels of triiodothyronine in dialyzed patients (author's transl)].
    Racek J; Slabý P; Holecek V
    Cas Lek Cesk; 1981 Jun; 120(24):733-5. PubMed ID: 7296619
    [No Abstract]   [Full Text] [Related]  

  • 19. [EEG-changes during haemodialysis in chronic renal insufficiancy (author's transl)].
    Brass N
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1980 Mar; 11(1):51-7. PubMed ID: 6773742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relative concentration of VLDL C-apolipoproteins in the hyperlipoproteinaemia of haemodialysis-treated chronic renal failure (author's transl)].
    Dewailly P; Dedonder E; Fruchart JC; Sezille G; Jaillard J
    Diabete Metab; 1980 Mar; 6(1):13-6. PubMed ID: 7371894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.